Medical Tubing Market - Insights
Medical tubes are intrinsic part of various medical devices, used extensively in catheters and cannulas’ manufacturing, drug delivery systems, dialysis, and intravenous tubing. Medical tubes are usually a small plastic tube, which are inserted into the patient’s body through mouth, nose, or any cut in skin to deliver oxygen, anesthesia, drugs, or any other fluid.
Generally, the structure of medical tubes becomes more complex with decrease in size of the tube. The medical tubes are available in a variety of shapes and sizes to satisfy demand for medical tubing in various applications. The manufacturers are also focusing on advancements of raw materials of medical tubing, as the materials vary with application and chemical nature of the drug.
Materials such as silicone, polytetrafluoroethylene (PTFE), polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polycarbonate (PC), bioabsorbable polymers, polyester, thermoplastic polyurethane (TPU), and thermoplastic elastomers (TPE) are used in medical and pharmaceutical applications, such as peristaltic pump tubing, catheter, feeding tubes, urological retrieval devices, among others. Silicone is the most preferred material in medical tubing, owing to its higher resistance towards extreme temperatures and non-toxicity. Raw materials play an essential role in the manufacturing of medical tubing, as incompatibility of material can lead to serious problems such as chemical alteration of drugs and medicines. Also, incompatible tube materials might lead to binding of chemical or drug to the wall of medical tube, resulting in failure of drug delivery to patient.
Increasing number of minimally invasive surgeries and its high adoption in medical devices, is enabling manufacturers to focus on the advancements of tubing functionality such as number of lumens, deflection capability, and steerability. For instance, according to American Society of Plastic Surgeons (ASPS) statistics, there were 17.1 million surgical and minimally invasive cosmetic procedures performed in the U.S. in 2016. Moreover, medical tubing is mostly used for respiratory and fluid management process in a patient’s body.
The global medical tubing market size is estimated to be valued at US$ 6,921.1 million in 2018, and is expected to witness a CAGR of 8.4% over the forecast period (2018–2026).
Global Medical Tubing Market Share (Value Terms), by Region, 2018
Source: Coherent Market Insights Analysis (2018)
Increasing Prevalence of Chronic Diseases and Life Threatening Diseases is Expected to Augment Market Growth
Increasing prevalence of chronic diseases and life threatening diseases is expected to drastically increase demand for medical tubing devices, which are essentially required during surgery procedures. For instance, according to a study published by National Center for Biotechnology Information in 2015, it was estimated that around 5.7 million people suffered from heart failure in the U.S. Moreover, according to Centers for Disease Control and Prevention (CDC), 2017, around 610,000 people die of heart disease in the U.S. every year.
According to a report published by the Australian Government, Department of Health in 2017, it was estimated that 1 in every 2 Australians (50%) suffers from at least one type of chronic condition, such as arthritis, asthma, back pain, cancer, cardiovascular disease, chronic obstructive pulmonary disease, diabetes or mental health conditions. Thus, high prevalence of chronic diseases and life threatening diseases is expected to be one of the major factors driving growth of the global medical tubing market.
Global Medical Tubing Market Share (Value terms), By Application: 2018 & 2026
Source: Coherent Market Insights Analysis (2018)
Furthermore, launches of advanced medical tubing solutions with latest technological features are expected to offer prominent growth opportunity for medical tubing manufacturers in the market.
For instance, in 2017, ART Medical Ltd., Israel-based startup, developed a novel sensor-based smart tube that enables healthcare professional to collect comprehensive patient data and reduces the risk of medical complications. This novel medical tube is able to gather the patient data such as feeding needs, saliva secretion, and urine output by using sensors embedded in the tubes. It also aid in regulating the feeding process and provides real-time information, including the exact location of the tube. Launches of such novel and smart medical tubing in future is enable to continue the technological advancement in the medical tubing, during the forecast period.
However, side effects related to materials used in manufacturing of medical tubing is expected to restrain the growth of market. For instance, in February 2017, U.S. Food and Drug Administration (FDA) pointed out that DEHP (di-2-ethylhexyl phthalate), which is used in PVC as a plasticizer (softener), may be absorbed into blood and body fluids, causing health problems. In addition, European Commission issued a notification in February 2016, referring the safety of medical devices containing DEHP- plasticized PVC or other plasticizers on neonates and other groups.
In 2012, Kaiser Permanente, an American-managed care consortium, banned PVC tubing and bags, and adopted 100% PVC and DEHP (di-2-ethyl hexyl phthalate) free intravenous tubing. Hence, side effects related to medical tubing material is expected to restrain growth of the market.
North America held a dominant position in the global medical tubing market in 2017 and is expected to retain its dominance over the forecast period. This is owing to the rising number of patient admissions in emergency wards, due to critical health conditions and severe injuries that require external support for survival. For instance, according to Society of Critical Care Medicine, in 2015, over 5.7 million patients were admitted in the intensive care units (ICU) in the U.S. for intensive or invasive monitoring, airway support, stabilization of chronic medical problems, and breathing disorders.
Furthermore, Asia Pacific is expected to witness a significant growth in the market during the forecast period, owing to developments in healthcare infrastructure, rising health awareness regarding benefits of prevention and wellness among patients, and development of innovative and cost-effective medical tubing solutions. In August 2017, Tekni-plex started a new production-manufacturing site near Shanghai in China, to satisfy rising needs of the Asia Pacific pharmaceutical and medical device market. This new facility produces Natvar’s silicone extrusion tubing for catheters, feeding tubes, drug delivery, and peristaltic pump applications. Navtar is Tekni-plex’s global supplier of precision medical tubing solutions for wide range of medical device products.
Some of the key players operating in the medical tubing market are Compagnie de Saint-Gobain S.A., Teleflex Incorporated, Optinova Holding AB, Zeus Industrial Products, Inc., The Lubrizol Corporation, Nordson Corporation, Putnam Plastics Corporation, Raumedic AG, Tekni-Plex, Inc., and Smith Group plc.